You're invited to a Brainlab Novalis Circle webinar on Wednesday, September 24, taking place just ahead of the ASTRO Annual Meeting.
Improved decision making with longitudinal brain metastases management
Join us for two expert presentations highlighting the latest advancements in radiosurgery for brain metastases. The session will conclude with an interactive Q&A.
Agenda:
Early retreatment based on Elements Contrast Clearance Analysis leads to improved outcomes in patients with brain metastases
@Dheerendra Prasad, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Clinical workflow optimization via new AI solutionsÂ
@Wenyin Shi, MD, PhD, Thomas Jefferson University Hospital, Philadelphia, PA, USA
Date: Wednesday, September 24, 2025
Time: 1:00 PM PT | 4:00 PM ET | 10:00 PM CET
Don't miss this opportunity to hear from leading researchers and clinicians shaping the future of radiosurgical treatment.
We look forward to seeing you there!
Participation is only possible for Novalis Circle Members. If you are not yet a member, please click here.
Hi, We lost access to Exactrac and added CRAD surface imaging on our Edge linac. We have adapted CRAD for targets in the abdomen, peripherals, and DIBH of breasts. Wonder if anyone has been able to use CRAD for cranial SRS treatments using an open-face mask?
You're invited to a Brainlab Novalis Circle webinar on Thursday, July 24, taking place just ahead of the AAPM Annual Meeting.
Advancing longitudinal radiosurgical management of multiple brain metastases with dedicated, indication-specific Elements.
Join us for two expert presentations highlighting the latest advancements in radiosurgery for multiple brain metastases. The session will conclude with an interactive Q&A.
Agenda:
Normal tissue sparing by an integrated VMAT planning in single isocenter dynamic conformal arc SRS plan for multiple brain metastases
@Haisong Liu, PhD, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, USA
Advancements in small field dosimetry for radiosurgery: Precision and challenges in treatment planning
@Paul RĂ©tif, PhD, CHR Metz-Thionville, Metz, France
Date: Thursday, July 24
Time: 8:00 AM PT | 11:00 AM ET | 5:00 PM CET
Don't miss this opportunity to hear from leading researchers and clinicians shaping the future of radiosurgical treatment.
We look forward to seeing you there!
Participation is only possible for Novalis Circle Members. If you are not yet a member, please click here.
Brainlab Novalis Circle le invita a unirse a el proximo webinar en directo Avances en el tratamiento de las metástasis cerebrales múltiples: Análisis y experiencia institucional.
En este webinar abordaremos el tratamiento de las metástasis cerebrales mĂşltiples, con especial atenciĂłn a los enfoques terapĂ©uticos innovadores y la experiencia institucional. Descubre cĂłmo las tecnologĂas innovadoras pueden ofrecer resultados prometedores para los pacientes con metástasis cerebrales mĂşltiples.
-   Tratamiento de Metástasis MĂşltiples CerebralesÂ
Sergio Moreno-JimĂ©nez, MD, Instituto Nacional de NeurologĂa y Neurocirugia (INNN), Mexico City, MĂ©xico
- Tratamiento de metástasis cerebrales múltiples con isocentro único: Experiencia Institucional
@Raquel Ciervide, MD PhD, HM Hospital Universitario Sanchinarro, Madrid, España
¡Esperamos encontrarnos con usted en lĂnea!
La participaciĂłn sĂłlo es posible para los miembros del Novalis Circle. Si aĂşn no es miembro, haga clic aquĂ.
Exciting News!
Join us in Columbus, Ohio for the Brainlab Regional Symposium — our first U.S. event of the year — happening June 13–14, 2025!
This 1½-day symposium will bring together clinicians, physicists, and innovators from across the region to explore the latest breakthroughs in radiation oncology, featuring Brainlab’s cutting-edge SRS and SBRT solutions. From cranial SRS to extracranial treatments like DIBH breast, prostate, and lung applications — there's something for every aspect of clinical practice.
Pleas find the agenda attached
Click https://lnkd.in/e3e7czKn to register or scan the QR code in the attached flyer.
Looking forward to seeing you there!
Join us in Warsaw on June 24th, 2025, for the Brainlab Central Europe SRS & SBRT Symposium 2025. Experience an inspiring lineup of expert talks and engaging discussions on cutting-edge developments in radiotherapy and radiosurgery.
Highlights of the symposium:
- Discover advancements:Â Â Attend scientific talks and explore the latest techniques in precision, personalization, and standardization of SRS & SBRT.
- Join interactive sessions:Â Â Take part in live demonstrations and dynamic discussions that will shape the future of patient care.
- Network with experts:  Engage with leading professionals in the field and connect with peers from across Central Europe. Â
We look forward to welcoming you to Warsaw this June! Click here to learn more: Welcome | Brainlab
Hello,
We have a case of a 43 yrs old female with metastatic brain mets from inflammatory bilateral breast. Last May we treated 15 brain mets with CK. She had an overall great response, but she now presents with 1 new lesion and 1 lesion with progression. Luckily both lesions are in the Frontal lobe and far from any OARs. We were planning to do 30Gy/5fx. Are there any thoughts on a different approach for prescription in this case? What is your clinics policy with retreatment for brain in regard to dose and normal brain constraints?
Thank you and I look forward to any feedback.
Join us in Brussels for a vibrant evening with insightful clinical talks by renowned clinical experts and inspirational discussions on SRS & SBRT.
Experience cutting edge of radiotherapy and radiosurgery at our exciting sunset symposium focused on precision, personalization, and standardization in Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT). This event will bring together clinicians, medical physicists, and radiation oncologists to share valuable clinical techniques and innovative management strategies, as well as insights into the transformative impact of big data in the field of SRS & SBRT.
We look forward to welcoming you to Brussels for this inspiring event! Click here to learn more: Welcome | Brainlab
Wir laden Sie herzlich ein zu unserem DACH Radiotherapie Symposium zum Thema Präzision, Personalisierung und Standardisierung in der stereotaktischen Radiochirurgie und Radiotherapie am 24. Januar 2025 im Brainlab Headquarter in München.
Klinische Anwender:innen und Fachkolleg:innen werden Erfahrungen und Fallstudien aus dem klinischen Alltag präsentieren und freuen sich auf spannende Diskussionen sowie den Austausch mit Ihnen.
Mehr information hier
Join the Symposium!
The Brainlab UK & Ireland Radiotherapy Symposium 2024 will focus on precision, personalization and evolution in radiotherapy and radiosurgery.
Led by the Charing Cross Hospital team, this meeting is an opportunity for clinicians, medical physicists and radiation oncologists to share insights on clinical techniques, exchange management approaches, tools and the use of big data in radiotherapy and radiosurgery treatments.
Attendees have the opportunity to take part in scientific talks, live demonstrations and informative discussions.
We look forward to seeing you all in London!
To register click here
We’re pleased to host the Advanced Clinical Course “Brain Metastases and Skull-base Tumors” in cooperation with Centre Hospitalier Princesse Grace and the team of Dr. Cécile Ortholan and Benjamin Serrano, PhD.
This Advanced Clinical Course will provide participants with the opportunity to learn from clinical experts about the clinical implementation and requirements for a successful radiosurgery program for brain metastases and skull-base tumors. During the course, medical physicists will learn about specific quality assurance techniques as well as expert tricks for treatment planning with Brainlab radiosurgery software. Radiation oncologists and neurosurgeons will learn about contouring, clinical prescriptions and planning approaches.
More information here
Interested? Contact your local Brainlab Sales representative.
*Please note: A Brainlab Academy ticket is needed to be able to attend this course.